- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
James W. Boswell III (Jim)
Event 19 results
Webinar
January 26, 2021
An Update on Payer Specialty Pharmacy Policies, How the Industry is Responding to Them, and What is at Stake for Hospitals
Webinar
December 9, 2020
COVID-19’s Impact on the Senior Care Industry: A Discussion on Crisis Management in the Face of Litigation and Enforcement Activity
Webinar
November 10, 2020
Challenging Payers’ New Specialty Pharmacy Policies That Reduce Payment to Hospitals
Webinar
Webinar
May 22, 2020
Part Two: COVID-19: How to Get Paid by Commercial, Managed Medicare and Managed Medicaid Payers in the Months to Come
Webinar
Webinar
April 3, 2020
Latest Congressional and CMS Actions Related to COVID-19
Webinar
March 19, 2020
Impact of CMS’s Section 1135 Waiver on Hospital Operations and Reimbursement During the Coronavirus Pandemic
Webinar
October 16, 2019
Surprise Billing Laws
Speaking Engagement
May 2, 2019
Jim Boswell to Speak at 2019 Multi-State Managed Care Conference
Webinar
February 27, 2019
Strategies for Challenging Health Plan Policies That Impact Coverage and Reimbursement
Speaking Engagement
February 2, 2019
Jim Boswell, Glenn Solomon to Speak at Revive Health Summit